Connection

Xingbao Li to Humans

This is a "connection" page, showing publications Xingbao Li has written about Humans.
Connection Strength

0.392
  1. Reduced executive and reward connectivity is associated with smoking cessation response to repetitive transcranial magnetic stimulation: A double-blind, randomized, sham-controlled trial. Brain Imaging Behav. 2024 Feb; 18(1):207-219.
    View in: PubMed
    Score: 0.036
  2. Two weeks of image-guided left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation improves smoking cessation: A double-blind, sham-controlled, randomized clinical trial. Brain Stimul. 2020 Sep - Oct; 13(5):1271-1279.
    View in: PubMed
    Score: 0.028
  3. Transcranial magnetic stimulation of the dorsal lateral prefrontal cortex inhibits medial orbitofrontal activity in smokers. Am J Addict. 2017 Dec; 26(8):788-794.
    View in: PubMed
    Score: 0.023
  4. Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers. Drug Alcohol Depend. 2017 05 01; 174:98-105.
    View in: PubMed
    Score: 0.022
  5. Safe management of a bipolar depressed patient with prefrontal repetitive transcranial magnetic stimulation (rTMS) Over 7 years and >2 million stimuli. Brain Stimul. 2014 Nov-Dec; 7(6):919-21.
    View in: PubMed
    Score: 0.019
  6. Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study. Drug Alcohol Depend. 2013 Dec 01; 133(2):641-6.
    View in: PubMed
    Score: 0.018
  7. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry. 2013 Apr 15; 73(8):714-20.
    View in: PubMed
    Score: 0.017
  8. Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol. 2013 Jul; 18(4):739-48.
    View in: PubMed
    Score: 0.016
  9. Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res. 2011 Nov 30; 194(2):141-8.
    View in: PubMed
    Score: 0.015
  10. Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology (Berl). 2010 Apr; 209(3):233-44.
    View in: PubMed
    Score: 0.014
  11. Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm (Vienna). 2009 Apr; 116(4):423-9.
    View in: PubMed
    Score: 0.013
  12. SPECT study of Chinese schizophrenic patients suggests that cerebral hypoperfusion and laterality exist in different ethnic groups. World J Biol Psychiatry. 2005; 6(2):98-106.
    View in: PubMed
    Score: 0.010
  13. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology. 2004 Jul; 29(7):1395-407.
    View in: PubMed
    Score: 0.009
  14. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004 May 01; 55(9):882-90.
    View in: PubMed
    Score: 0.009
  15. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety. 2004; 20(2):98-100.
    View in: PubMed
    Score: 0.009
  16. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial. Brain Stimul. 2023 Nov-Dec; 16(6):1753-1763.
    View in: PubMed
    Score: 0.009
  17. Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol. 2003 Jun; 16(2):128-35.
    View in: PubMed
    Score: 0.009
  18. Cigarette smoking and schizophrenia independently and reversibly altered intrinsic brain activity. Brain Imaging Behav. 2018 Oct; 12(5):1457-1465.
    View in: PubMed
    Score: 0.006
  19. Individualized real-time fMRI neurofeedback to?attenuate craving in nicotine-dependent smokers. J Psychiatry Neurosci. 2016 Jan; 41(1):48-55.
    View in: PubMed
    Score: 0.005
  20. Antidepressant Effects of Electroconvulsive Therapy Correlate With Subgenual Anterior Cingulate Activity and Connectivity in Depression. Medicine (Baltimore). 2015 Nov; 94(45):e2033.
    View in: PubMed
    Score: 0.005
  21. A comprehensive study of sensorimotor cortex excitability in chronic cocaine users: Integrating TMS and functional MRI data. Drug Alcohol Depend. 2015 Dec 01; 157:28-35.
    View in: PubMed
    Score: 0.005
  22. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl). 2014 Sep; 231(18):3799-807.
    View in: PubMed
    Score: 0.005
  23. Sustained reduction of nicotine craving with real-time neurofeedback: exploring the role of severity of dependence. Nicotine Tob Res. 2013 Dec; 15(12):2120-4.
    View in: PubMed
    Score: 0.004
  24. Probing the frontostriatal loops involved in executive and limbic processing via interleaved TMS and functional MRI at two prefrontal locations: a pilot study. PLoS One. 2013; 8(7):e67917.
    View in: PubMed
    Score: 0.004
  25. Reduction of cue-induced craving through realtime neurofeedback in nicotine users: the role of region of interest selection and multiple visits. Psychiatry Res. 2013 Jul 30; 213(1):79-81.
    View in: PubMed
    Score: 0.004
  26. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37.
    View in: PubMed
    Score: 0.004
  27. Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS. Neuropsychopharmacology. 2013 Jun; 38(7):1189-97.
    View in: PubMed
    Score: 0.004
  28. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22.
    View in: PubMed
    Score: 0.004
  29. Real-time fMRI in the treatment of nicotine dependence: a conceptual review and pilot studies. Psychol Addict Behav. 2013 Jun; 27(2):501-9.
    View in: PubMed
    Score: 0.004
  30. Individual variability in the locus of prefrontal craving for nicotine: implications for brain stimulation studies and treatments. Drug Alcohol Depend. 2012 Oct 01; 125(3):239-43.
    View in: PubMed
    Score: 0.004
  31. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul. 2013 Mar; 6(2):108-17.
    View in: PubMed
    Score: 0.004
  32. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol. 2011 Oct; 16(4):654-66.
    View in: PubMed
    Score: 0.004
  33. Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT. 2011 Mar; 27(1):5-10.
    View in: PubMed
    Score: 0.004
  34. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
    View in: PubMed
    Score: 0.004
  35. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage. 2011 May 01; 56(1):61-8.
    View in: PubMed
    Score: 0.004
  36. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72.
    View in: PubMed
    Score: 0.004
  37. Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans. 2009 Oct; 37(Pt 5):1080-4.
    View in: PubMed
    Score: 0.003
  38. Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT. 2009 Jun; 25(2):91-8.
    View in: PubMed
    Score: 0.003
  39. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75.
    View in: PubMed
    Score: 0.003
  40. Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimul. 2008 Jan; 1(1):44-51.
    View in: PubMed
    Score: 0.003
  41. Functional neuroanatomy of subcomponent cognitive processes involved in verbal working memory. Int J Neurosci. 2005 Jul; 115(7):1017-32.
    View in: PubMed
    Score: 0.003
  42. The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision. J ECT. 2004 Sep; 20(3):160-5.
    View in: PubMed
    Score: 0.002
  43. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol. 2004 Jun; 17(2):109-17.
    View in: PubMed
    Score: 0.002
  44. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology. 2004 Feb; 29(2):393-402.
    View in: PubMed
    Score: 0.002
  45. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.
    View in: PubMed
    Score: 0.002
  46. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr. 2003 Jul; 8(7):496-514.
    View in: PubMed
    Score: 0.002
  47. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
    View in: PubMed
    Score: 0.002
  48. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
    View in: PubMed
    Score: 0.002
  49. Mechanisms and state of the art of transcranial magnetic stimulation. J ECT. 2002 Dec; 18(4):170-81.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.